Division of Genetics and Genomics, Manton Center for Orphan Disease, Boston Children's Hospital, Boston, Massachusetts.
Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.
Cancer Discov. 2022 Jan;12(1):172-185. doi: 10.1158/2159-8290.CD-21-0245. Epub 2021 Aug 13.
Although oncogenic mutations have been found in nondiseased, proliferative nonneural tissues, their prevalence in the human brain is unknown. Targeted sequencing of genes implicated in brain tumors in 418 samples derived from 110 individuals of varying ages, without tumor diagnoses, detected oncogenic somatic single-nucleotide variants (sSNV) in 5.4% of the brains, including . These mutations were largely present in subcortical white matter and enriched in glial cells and, surprisingly, were less common in older individuals. A depletion of high-allele frequency sSNVs representing macroscopic clones with age was replicated by analysis of bulk RNA sequencing data from 1,816 nondiseased brain samples ranging from fetal to old age. We also describe large clonal copy number variants and that sSNVs show mutational signatures resembling those found in gliomas, suggesting that mutational processes of the normal brain drive early glial oncogenesis. This study helps understand the origin and early evolution of brain tumors. SIGNIFICANCE: In the nondiseased brain, clonal oncogenic mutations are enriched in white matter and are less common in older individuals. We revealed early steps in acquiring oncogenic variants, which are essential to understanding brain tumor origins and building new mutational baselines for diagnostics..
虽然在非疾病、增殖性非神经组织中已经发现了致癌突变,但它们在人类大脑中的普遍性尚不清楚。对来自 110 名不同年龄个体的 418 个样本中涉及脑肿瘤的基因进行靶向测序,这些样本没有肿瘤诊断,在 5.4%的大脑中检测到致癌性体细胞单核苷酸变异(sSNV),包括. 这些突变主要存在于皮质下白质中,在神经胶质细胞中富集,令人惊讶的是,在老年人中较少见。通过对 1816 个从胎儿到老年的非疾病脑样本的大量 RNA 测序数据进行分析,复制了随着年龄增长而大量出现的高等位基因频率 sSNV 的耗竭,这些 sSNV 代表了具有宏观克隆的等位基因频率。我们还描述了大的克隆拷贝数变异,并且 sSNV 显示出与神经胶质瘤中发现的相似的突变特征,这表明正常大脑的突变过程驱动了早期神经胶质的癌变。这项研究有助于理解脑肿瘤的起源和早期演变。意义:在非疾病大脑中,克隆性致癌突变在白质中富集,在老年人中较少见。我们揭示了获得致癌变异的早期步骤,这对于理解脑肿瘤的起源和为诊断建立新的突变基准至关重要。